Vesicle Therapeutics
Niwot, US · Founded 2020 · Delaware corporation
Founders & leadership
XL
Xuedong LiuNamed on SEC filing
DP
Donna PeakNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$800K disclosed across 1 round · 2022
▶$800KraisedApr 2022 · 4 investors · BiotechnologyRule 506(b)
▶$800KraisedApr 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xuedong LiuExecutive Officer, Director
- Donna PeakExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $800K
- Minimum investment
- $100K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Vesicle Therapeutics raised?
- Vesicle Therapeutics has disclosed $800K raised across 1 round.
- Where is Vesicle Therapeutics headquartered?
- Vesicle Therapeutics is headquartered in Niwot, US.